1. India Stocks

  2. •

    Healthcare

  3. •

    Medical - Pharmaceuticals
Gujarat Themis Biosyn Limited

Gujarat Themis Biosyn Limited

GUJTHEM.BO
Gujarat Themis Biosyn LimitedIN flagBombay Stock Exchange
377.10
INR
-6.25
- -
41.09BMarket Cap

Total Valuation

Gujarat Themis Biosyn Limited carries a market capitalization of 41.09B, placing it among publicly traded companies globally. Its enterprise value stands at 26.36B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap41.09B
Enterprise Value26.36B

Share Statistics

Gujarat Themis Biosyn Limited currently has 108.97M shares outstanding.

Shares Outstanding108.97M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Gujarat Themis Biosyn Limited trades at a trailing price-to-earnings ratio of 53.15. The price-to-sales ratio is 14.96, and the price-to-book ratio stands at 227.69.

PE Ratio53.15
PS Ratio14.96
PB Ratio227.69
P/TBV Ratio8.62
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Gujarat Themis Biosyn Limited trades at an EV/EBITDA multiple of 42.11 and an EV/FCF ratio of 1,189.12. The EV/Sales ratio of 15.90 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 42.11 provides insight into valuation relative to core operating earnings.

EV / Sales15.90
EV / EBITDA42.11
EV / EBIT42.11
EV / FCF1,189.12

Financial Position

Gujarat Themis Biosyn Limited maintains a current ratio of 1.12, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 56.23, indicating elevated leverage, while an interest coverage ratio of 21.23 demonstrates strong ability to service its debt obligations.

Current Ratio1.12
Quick Ratio0.08
Debt / Equity56.23
Debt / EBITDA2.58
Interest Coverage21.23

Financial Efficiency

Gujarat Themis Biosyn Limited posts a return on equity of 428.41 and a return on invested capital of 12.92.

Return on Equity (ROE)428.41
Return on Assets (ROA)11.60
Return on Invested Capital (ROIC)12.92
Return on Capital Employed (ROCE)45.68
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover2.69

Taxes

Over the trailing twelve months, Gujarat Themis Biosyn Limited has paid 154.09M in income taxes, reflecting an effective tax rate of 24.82.

Income Tax154.09M
Effective Tax Rate24.82

Stock Price Statistics

Gujarat Themis Biosyn Limited's stock has gained approximately 8.95695% over the past 52 weeks. The 50-day moving average sits at 385.84, while the 200-day moving average is 371.36.

Beta (5Y)N/A
52-Week Price Change8.95695%
50-Day Moving Average385.84
200-Day Moving Average371.36
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Gujarat Themis Biosyn Limited generated 1.66B in revenue and converted that into 466.81M in net income, yielding earnings per share of 4.28. EBITDA reached 626.11M, while operating income came in at 626.11M.

Revenue1.66B
Gross Profit1.38B
Operating Income626.11M
Pretax Income620.90M
Net Income466.81M
EBITDA626.11M
EBIT626.11M
Earnings Per Share (EPS)4.28

Balance Sheet

Gujarat Themis Biosyn Limited holds 64.18M in cash and equivalents against 1.62B in total debt, resulting in a net debt position of 1.57B. Total book value stands at 108.97M, with working capital of 96.36M providing operational flexibility.

Cash & Cash Equivalents64.18M
Total Debt1.62B
Net Debt1.57B
Equity (Book Value)108.97M
Book Value Per Share1.00
Working Capital96.36M

Margins

Gujarat Themis Biosyn Limited operates with a gross margin of 83.37, reflecting its pricing power and cost economics. The operating margin of 37.76 and net profit margin of 28.15 provide insight into operational efficiency.

Gross Margin83.37
Operating Margin37.76
Pretax Margin37.44
Profit Margin28.15
EBITDA Margin37.76

Stock Splits

Gujarat Themis Biosyn Limited's most recent stock split took place on August 9, 2024 with a 2:3 split ratio.

Last Split Date8/9/2024
Split Ratio2:3

Scores

Gujarat Themis Biosyn Limited posts an Altman Z-Score of 7.67, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score7.67